These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 19234517)
1. The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis. Hartman TR; Nicolas E; Klein-Szanto A; Al-Saleem T; Cash TP; Simon MC; Henske EP Oncogene; 2009 Apr; 28(13):1594-604. PubMed ID: 19234517 [TBL] [Abstract][Full Text] [Related]
2. The Birt-Hogg-Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe. van Slegtenhorst M; Khabibullin D; Hartman TR; Nicolas E; Kruger WD; Henske EP J Biol Chem; 2007 Aug; 282(34):24583-90. PubMed ID: 17556368 [TBL] [Abstract][Full Text] [Related]
3. Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. Baba M; Furihata M; Hong SB; Tessarollo L; Haines DC; Southon E; Patel V; Igarashi P; Alvord WG; Leighty R; Yao M; Bernardo M; Ileva L; Choyke P; Warren MB; Zbar B; Linehan WM; Schmidt LS J Natl Cancer Inst; 2008 Jan; 100(2):140-54. PubMed ID: 18182616 [TBL] [Abstract][Full Text] [Related]
4. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin. Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504 [TBL] [Abstract][Full Text] [Related]
5. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. Chen J; Futami K; Petillo D; Peng J; Wang P; Knol J; Li Y; Khoo SK; Huang D; Qian CN; Zhao P; Dykema K; Zhang R; Cao B; Yang XJ; Furge K; Williams BO; Teh BT PLoS One; 2008; 3(10):e3581. PubMed ID: 18974783 [TBL] [Abstract][Full Text] [Related]
6. Renal angiomyolipoma in Birt-Hogg-Dube syndrome: A case study supporting overlap with tuberous sclerosis complex. Dow E; Winship I Am J Med Genet A; 2016 Dec; 170(12):3323-3326. PubMed ID: 27643397 [TBL] [Abstract][Full Text] [Related]
7. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Hasumi Y; Baba M; Ajima R; Hasumi H; Valera VA; Klein ME; Haines DC; Merino MJ; Hong SB; Yamaguchi TP; Schmidt LS; Linehan WM Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18722-7. PubMed ID: 19850877 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary cysts of Birt-Hogg-Dubé syndrome: a clinicopathologic and immunohistochemical study of 9 families. Furuya M; Tanaka R; Koga S; Yatabe Y; Gotoda H; Takagi S; Hsu YH; Fujii T; Okada A; Kuroda N; Moritani S; Mizuno H; Nagashima Y; Nagahama K; Hiroshima K; Yoshino I; Nomura F; Aoki I; Nakatani Y Am J Surg Pathol; 2012 Apr; 36(4):589-600. PubMed ID: 22441547 [TBL] [Abstract][Full Text] [Related]
9. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome. Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100 [TBL] [Abstract][Full Text] [Related]
10. Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissues. Warren MB; Torres-Cabala CA; Turner ML; Merino MJ; Matrosova VY; Nickerson ML; Ma W; Linehan WM; Zbar B; Schmidt LS Mod Pathol; 2004 Aug; 17(8):998-1011. PubMed ID: 15143337 [TBL] [Abstract][Full Text] [Related]
11. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas. Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015 [TBL] [Abstract][Full Text] [Related]
12. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. Takagi Y; Kobayashi T; Shiono M; Wang L; Piao X; Sun G; Zhang D; Abe M; Hagiwara Y; Takahashi K; Hino O Oncogene; 2008 Sep; 27(40):5339-47. PubMed ID: 18663353 [TBL] [Abstract][Full Text] [Related]
13. Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations. Adley BP; Smith ND; Nayar R; Yang XJ Arch Pathol Lab Med; 2006 Dec; 130(12):1865-70. PubMed ID: 17149965 [TBL] [Abstract][Full Text] [Related]
14. Loss of the Birt-Hogg-Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription. Cash TP; Gruber JJ; Hartman TR; Henske EP; Simon MC Oncogene; 2011 Jun; 30(22):2534-46. PubMed ID: 21258407 [TBL] [Abstract][Full Text] [Related]
16. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174 [TBL] [Abstract][Full Text] [Related]
17. Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis. Sager RA; Woodford MR; Shapiro O; Mollapour M; Bratslavsky G Oncotarget; 2018 Apr; 9(31):22220-22229. PubMed ID: 29774133 [TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling. Hong SB; Oh H; Valera VA; Stull J; Ngo DT; Baba M; Merino MJ; Linehan WM; Schmidt LS Mol Cancer; 2010 Jun; 9():160. PubMed ID: 20573232 [TBL] [Abstract][Full Text] [Related]
19. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome. Nishii T; Tanabe M; Tanaka R; Matsuzawa T; Okudela K; Nozawa A; Nakatani Y; Furuya M Pathol Int; 2013 Jan; 63(1):45-55. PubMed ID: 23356225 [TBL] [Abstract][Full Text] [Related]
20. Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma. Schmidt LS Curr Mol Med; 2004 Dec; 4(8):877-85. PubMed ID: 15579035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]